Guangzhou
China
Shantou
COVID-19; recurrence; SARS-CoV-2 RNA; pathogenicity; transmission
recurrence; COVID-19; SARS-CoV-2 RNA; relapse; transmission
Coronavirus Disease 2019; deterioration; time window; clinical course; pre-hospital risk factor
COVID-19; moderate; deterioration; time point; pattern